OWC Pharmaceutical Research Corp (OWCP)

[Farmer7]

MULTIPLE MYELOMA

cancer of plasma cells)
• Designed to be an Orphan Disease study approved by the FDA
• In-vitro study completed 06/2015 – Cannabis kills the MM cancer cells
• Pre-clinic study on mice completed 12/2015 – calibration phase for dosage, found most effective ratio of active cannabinoids THC/CBD
• In-vitro study for a combination of 4 approved drugs with cannabis completed 05/2016 – promising results
• Pre-clinic study for the most effective combination on mice with new cannabis extracts. On-going testing.
• SUBJECT TO ACHIEVING SCIENTIFIC MILESTONES THE COMPANY WILL SUBMITT AN APPLICATION WITH THE FDA FOR AN ORPHAN DISEASE DESIGNATION



We are down to the best delivery system now, oral or a suppository and this ends in Q3.....

Feeling good about the longterm future here!